loader image

Eos portfolio business, the cancer drug discovery accelerator Cumulus Oncology, launches its first spinout – Modulus Oncology

The move is the first of many with the aim of creating a major new force in Scottish biotech Cancer drug discovery accelerator Cumulus Oncology has become a key founder of start-up biotech company, Modulus Oncology. Edinburgh-based Cumulus is backing Modulus, a University of Sheffield spinout company that focuses on hard-to-treat cancers. Modulus is the … Read more

Latest news

SEIS limit increased to £250k
03 October 2022
Nodus Oncology launches, founded by Cumulus Oncology and in partnership with the Lead Discovery Center, to focus on developing first and best-in-class molecules inhibiting novel DNA damage response targets
06 September 2022

This website uses cookies to ensure you get the best experience on our website. By continuing to browse on this website, you accept the use of cookies for the above purposes.